Mechanism of action
Repaglinide lowers post-prandial blood glucose as well as fasting blood glucose in patients with type 2 diabetes mellitus by acting on the beta cells of pancreas.
Medical Articles
Repaglinide is a drug used in the treatment of diabetes mellitus type 2. It belongs to a class of antihyperglycemic agents known as meglitinides, along with nateglinide. Meglitinides work to reduce blood glucose levels by stimulating endogenous insulin production.
© 2025[current_year] The Doctors Platform. All Right Reserved.
© 2025 The Doctors Platform. All Right Reserved.